The QTc Effect of Low-Dose Methadone for Chronic Pain: A Prospective Pilot Study

Pain Medicine (United States)

Volumn 16, Issue 6, 2015, Pages 1112-1121

  Grodofsky, Samuel ^a   Edson, Emmanuel ^a   Huang, Stephanie ^a   Speck, Rebecca M ^a,b   Hatchimonji, Justin ^a   Lacy, Kim ^a   Farrar, John T ^a,b   Ashburn, Michael A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic Opioid Therapy; Methadone; QTc Prolongation

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC PAIN; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ELECTROCARDIOGRAPH; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PILOT STUDY; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; QT PROLONGATION; QTC INTERVAL; VERY ELDERLY; ADVERSE EFFECTS; CHEMICALLY INDUCED; DOSE RESPONSE; LONG QT SYNDROME; OPIATE SUBSTITUTION TREATMENT; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC PAIN; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LONG QT SYNDROME; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84932192945     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12658     Document Type: Article

References (39)

1. Kuehn BM. Methadone overdose deaths rise with increased prescribing for pain. JAMA 2012;308:749-50.
2. Paulozzi LJ. Vital signs: Risk for overdose from methadone used for pain relief-United States, 1999-2010. MMWR 2012;61:493-97.
3. McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: A review. Am J Addict 2010;19:4-16.
4. Chou R, Cruciani RA, Fiellin DA, et al. Methadone safety: A clinical practice guideline from the american pain society and college on problems of drug dependence, in collaboration with the heart rhythm society. J Pain 2014;15:321-37.
5. Andrews CM, Krantz MJ, Wedam EF, et al. Methadone-induced mortality in the treatment of chronic pain: Role of QT prolongation. Cardiology 2009;16:210-7.
6. Kao D, Bartelson BB, Khatri V, et al. Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: An analysis of registry data. Ann Intern Med 2013;158:735-40.
7. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mt Sinai J Med 2000;67:347-64.
8. Bart G. Maintenance medication for opiate addiction: The foundation of recovery. J Addict Dis 2012;31:207-25.
9. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003;2:CD002209.
10. Sandoval JA, Furlan AD, Mailis-Gagnon A. Oral methadone for chronic noncancer pain: A systematic literature review of reasons for administration, prescription patterns, effectiveness, and side effects. Clin J Pain 2005;21:503-12.
11. Mannino R, Coyne P, Swainey C, Hansen LA, Lyckholm L. Methadone for cancer-related neuropathic pain: A review of the literature. J Opioid Manag 2006;2:269-76.
12. Haroutiunian S, McNicol ED, Lipman AG. Methadone for chronic non-cancer pain in adults. Cochrane Database Syst Rev 2012;11:CD008025.
13. Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis 2010;29:1-14.
14. Fonseca F, Marti-Almor J, Pastor A, et al. Prevalence of long QTc interval in methadone maintenance patients. Drug Alcohol Depend 2009;99:327-32.
15. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Ann Intern Med 2009;150:387-95.
16. Maremmani I, Pacini M, Cesaroni C, et al. QTc interval prolongation in patients on long-term methadone maintenance therapy. Euro Addict Res 2005;11:44-9.
17. Roy AK, McCarthy C, Kiernan G, et al. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Addiction 2012;107:1132-9.
18. Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: A mortality assessment study. Addiction 2009;104:993-9.
19. Ehret GB, Voide C, Gex-Fabry M, et al. Drug-induced long QT syndrome in injection drug users receiving methadone: High frequency in hospitalized patients and risk factors. Arch Intern Med 2006;166:1280-7.
20. Chou R, Weimer MB, Dana T. Methadone overdose and cardiac arrhythmia potential: Findings from a review of the evidence for an american pain society and college on problems of drug dependence clinical practice guideline. J Pain 2014;15:338-65.
21. Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: Reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005;14:747-53.
22. Stallvik M, Nordstrand B, Kristensen O, et al. Corrected QT interval during treatment with methadone and buprenorphine-Relation to doses and serum concentrations. Drug Alcohol Depend 2013;129:88-93.
23. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 2003;23:802-5.
24. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
25. Inturrisi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 1987;41:392-401.
26. van den Beuken-van Everdingen MH, Geurts JW, Patijn J. Prolonged QT interval by methadone: Relevance for daily practice? A prospective study in patients with cancer and noncancer pain. J Opioid Manag 2013;9:263-7.
27. Huh B, Park CH. Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients. Korean J Anesthesiol 2010;58:338-43.
28. Reddy S, Hui D, Osta BE, et al. The effect of oral methadone on the QTc Interval in advanced cancer patients: A prospective pilot study. J Palliat Med 2010;13:33-8.
29. Reddy S, Fisch M, Bruera E. Oral methadone for cancer pain: No indication of Q-T interval prolongation or torsades de pointes. J Pain Symptom Manage 2004;28:301-3
30. Brouwer J, Van Den Berg MP, Grobbee DE, Haaksma J, Wilde AA. Diagnostic performance of various QTc interval formulas in a large family with long QT syndrome type 3: Bazett's formula not so bad after all. Ann Noninvasive Electrocardiol 2003;8:269-74.
31. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010;121:1047-60.
32. Straus SM, Kors JA, Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006;47:362-7.
33. Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther 2002;303:688-94.
34. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998;98:1928-36.
35. Thomas D, Karle CA, Kiehn J. Modulation of HERG potassium channel function by drug action. Ann Med 2004;36 (Suppl 1):41-6.
36. Cruciani RA, Sekine R, Homel P, et al. Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage 2005;29:385-91.
37. Chang KC, Huang CL, Liang HY, et al. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence. J Cardiovasc Electrophysiol 2012;23:527-33.
38. Dogan A, Tunc E, Varol E, Ozaydin M, Ozturk M. Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men. Ann Noninvasive Electrocardiol 2005;10:134-41.
39. Smetana P, Batchvarov V, Hnatkova K, Camm AJ, Malik M. Circadian rhythm of the corrected QT interval: Impact of different heart rate correction models. Pacing Clin Electrophysiol 2003;26:383-6.